FibroGen
0 followers
‌
FibroGen, Inc. is a science-based biopharmaceutical company discovering and developing a pipeline of first- in-class therapeutics. The Company is focused on fibrosis and hypoxia-inducible factor (HIF) biology and clinical development to advance innovative medicines for the treatment of anemia, fibro... Read more
Org chart
Percy H. Carter
Chief Scientific Officer
Christine L. Chung
SVP, China Operations
Pat Cotroneo
CFO
Richard Farley
VP, Human Resources
R. Wayne Frost
SVP, Regulatory Affairs
Elias Kouchakji
SVP, Clinical Development, Drug Safety, and Pharmacovigilance
Michael D. Lowenstein
Chief Legal Officer
Michael J. Martinelli
SVP, Technical Development
Leanne C. Price
Chief Intellectual Property Officer
Thane Wettig
Chief Executive Officer
Juan Graham
Chief Financial Officer
Kirk Christoffersen
Svp, Chief Business Officer
Simon Miller
Vice President Marketing
Tricia Stewart
Chief People Officer
Carol Gaddum
Executive Director, Forecasting, Analytics & New Product Planning
Claudia Witschi
Executive Director, Biologics Drug Product
Claudia Witschi
Executive Director, Biologics Drug Product
Akshaya Patel Pharm.d.
Head Of Field Medical
Dr. Olga V. Gambetti M.D., Ph.D., Drmedsci
Medical Director, Clinical Development
Aileen Huang (Cuihua)
Sr. Medical Manager
Bernardo Lomongsod
Associate Scientist 1
Dongxia Li
Principal Scientist
Elena Vaisberg
Associate Scientist
Gerardo Pangilinan Ms, Dabt
Principal Scientist
Gihani Wijewickrama
Principal Scientist CMC Analytical Development In Biologics
Guangjie Guo
Senior Scientist
Jung Min Park
Sr Scientist
Krithica Sanjana
Associate Scientist
Zhao Hongda
Scientist
Sarah Helgeson
Executive Director, Global Medical Writing, Publications, And Medical Information
